New Study Reinforces Safety Profile of GARDASIL Vaccine
共播放86次 0人加入我的最愛
newsinfusion| 簡介： | For more info visit www.newsinfusion.com WHITEHOUSE STATION, N.J., Aug. 18, 2009 – Merck is proud to have introduced GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], the world's first cervical cancer vaccine, a vaccine that can also help to prevent vulvar and vaginal cancers and genital warts caused by HPV types 6, 11, 16 and 18. The paper published in JAMA on Aug. 19 by the Centers for Disease Control and Prevention (CDC) is another important milestone in the medical community's ongoing effort to monitor the safety of vaccines, including GARDASIL. "We are pleased that the study published by JAMA today further reinforces the safety profile of GARDASIL. We welcome continued study and discussion about the safety of this important vaccine," said Richard M. Haupt, M.D., MPH, pediatrician and head of the clinical program for GARDASIL. ... |
|---|---|
| 日期： | 2009-08-20 |
| 分類： | 潮流 |
| 標籤： | |
| 網址： | |
| 轉貼： |
上載用戶其他清單
更多
顯示更多
